PharmaNutra SpA (IT:PHN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PharmaNutra S.p.A. has achieved significant sales growth in China for its SiderAL® brand products, surpassing €1 million in sales through major cross-border e-commerce platforms like TMall Global and Douyin. The success in 2024 has prompted the company to accelerate the introduction of its Apportal® line, aiming to replicate this successful strategy. This expansion reflects the growing demand for high-quality nutritional supplements in the Chinese market.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.